← Back to Search

Procedure

Chest tube placement for Empyema

N/A
Waitlist Available
Led By Bradley W Thomas, MD
Research Sponsored by Atrium Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Study Summary

This trial will compare 14 Fr thal tubes to 28 Fr chest tubes for non-emergent drainage of hemothorax and hemopneumothorax, with the goal of finding which is more effective with less pain.

Eligible Conditions
  • Empyema
  • Hemothorax
  • Traumatic Hemopneumothorax
  • Chest Tube

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants With Retained Hemothorax Following Initial Chest Tube Placement Requiring Intervention
Secondary outcome measures
Change in Subjective Pain Scores From Baseline at 90 Days
Duration of Chest Tube Placement.
Hemodynamic Stability Post-insertion
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: 28 French chest tube for hemothoraxExperimental Treatment1 Intervention
28 French straight chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax
Group II: 14 French chest tube for hemothoraxExperimental Treatment1 Intervention
14 French thal chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Chest tube placement
2017
N/A
~200

Find a Location

Who is running the clinical trial?

Atrium HealthLead Sponsor
121 Previous Clinical Trials
34,661 Total Patients Enrolled
Wake Forest University Health SciencesLead Sponsor
1,240 Previous Clinical Trials
1,004,014 Total Patients Enrolled
Bradley W Thomas, MDPrincipal InvestigatorWake Forest University Health Sciences

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Canadian Respiratory JournalJournal
Residual Hemothorax After Chest Tube Placement Correlates with Increased Risk of Empyema Following Traumatic Injury
Karmy-Jones, Riyad, Michele Holevar, Ryan J Sullivan, Ani Fleisig, and Gregory J Jurkovich. 2008. “Residual Hemothorax After Chest Tube Placement Correlates with Increased Risk of Empyema Following Traumatic Injury”. Canadian Respiratory Journal. Hindawi Limited. doi:10.1155/2008/918951.
Journal of Trauma and Acute Care SurgeryJournal
Does Size Matter? A Prospective Analysis of 28–32 Versus 36–40 French Chest Tube Size in Trauma
Inaba, Kenji, Thomas Lustenberger, Gustavo Recinos, Crysanthos Georgiou, George C. Velmahos, Carlos Brown, Ali Salim, Demetrios Demetriades, and Peter Rhee. 2012. “Does Size Matter? A Prospective Analysis of 28–32 Versus 36–40 French Chest Tube Size in Trauma”. Journal of Trauma and Acute Care Surgery. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/ta.0b013e3182452444.
versusJournal
Randomized Clinical Trial of Pigtail Catheter <i>versus</i> Chest Tube in Injured Patients with Uncomplicated Traumatic Pneumothorax
Kulvatunyou, N, L Erickson, A Vijayasekaran, L Gries, B Joseph, R F Friese, T O'Keeffe, A L Tang, J L Wynne, and P Rhee. 2013. “Randomized Clinical Trial of Pigtail Catheter versus Chest Tube in Injured Patients with Uncomplicated Traumatic Pneumothorax”. British Journal of Surgery. Oxford University Press (OUP). doi:10.1002/bjs.9377.
clinicaltrials.govStudy
Prospective Evaluation of 14F Thal Tube vs 28 French Chest Tube for Hemothorax and Use of Maximum Barrier Precautions
Bradley Thomas, M.D. 2017. "Prospective Evaluation of 14F Thal Tube vs 28 French Chest Tube for Hemothorax and Use of Maximum Barrier Precautions". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03167723.
~24 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top